COVID-19 trials registries data warehouse

http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44341

Neha Jaiswal

drpremnyati@gmail.com

2020-06-28

Not recruiting

RCT

Randomized

Parallel

Blind label

single-center

Treatment

patients of both genders who aged between 10 years to 55 years with confirmation of COVID-19 infection through RT-PCR test. Mild to moderate severity of disease who are willing to participate in study by giving written informed consent. <br/ >

seriously ill patients requiring ventilators support. <br/ >Children below 10 years, adults > 55 years of age. <br/ >

2

Index Medical College and research centre Indore

10

55

India

Mild/moderate disease at enrollment

2: Mild/moderate disease at enrollment

200

1. Effect of NAC in the study group on alleviating patientâ??s signs and Symptoms of COVID-19 in forms of severity and duration. <br/ >2. Rate of cure from the disease as measured by negative results of RT-PCR test on nasopharyngeal swabs <br/ >Timepoint: 5-7days from start of dose administration

| Declared number of arm (2.0) differs from found arms (3.0)

Not reported

[{"arm_notes": "", "treatment_id": 850, "treatment_name": "N-acetylcysteine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]